Microstructural abnormalities of substantia nigra in Parkinson's disease: A neuromelanin sensitive MRI atlas based study

Citations Over TimeTop 13% of 2019 papers

Abstract

Microstructural changes associated with degeneration of dopaminergic neurons of the substantia nigra pars compacta (SNc) in Parkinson's disease (PD) have been studied using Diffusion Tensor Imaging (DTI). However, these studies show inconsistent results, mainly due to methodological variations in delineation of SNc. To mitigate this, our work aims to construct a probabilistic atlas of SNc based on a 3D Neuromelanin Sensitive MRI (NMS-MRI) sequence and demonstrate its applicability to investigate microstructural changes on a large dataset of PD. Using manual segmentation and deformable registration we created a novel SNc atlas in the MNI space using NMS-MRI sequences of 27 healthy controls (HC). We first quantitatively evaluated this atlas and then employed it to investigate the micro-structural abnormalities in SNc using diffusion MRI from 133 patients with PD and 99 HCs. Our results demonstrated significant increase in diffusivity with no changes in anisotropy. In addition, we also observed an asymmetry of the diffusion metrics with a higher diffusivity and lower anisotropy in the left SNc than the right. Finally, a multivariate classifier based on SNc diffusion features could delineate patients with PD with an average accuracy of 71.7%. Overall, from this work we establish a normative baseline for the SNc region of interest using NMS-MRI while the application on PD data emphasizes on the contribution of diffusivity measures rather than anisotropy of white matter in PD.

Related Papers

• → Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease(2006)499 cited
• → Detecting parkinsonian degeneration in lateroventral tier of substantia nigra pars compacta with MRI(2020)2 cited
• → Synchrotron radiation based X-ray fluorescence shows changes in the elemental composition of the human substantia nigra in aged brains(2015)18 cited
• → Is neuromelanin the imaging biomarker for the early diagnosis of Parkinson's disease that we were looking for?(2018)4 cited
• → Isolation of Neuromelanin Granules(2008)3 cited